Your browser doesn't support javascript.
loading
Corrigendum to "BML-111, the lipoxin A4 agonist, modulates VEGF or CoCl2-induced migration, angiogenesis and permeability in tumor-derived endothelial cells"[Immunology Letters 230 (2021) 27-35].
Lin, Lan; Wang, Qingyu; Xu, Fen; Luo, Xuliang; Xu, Jing; Yan, Liping; Li, Qing; Hao, Hua.
Afiliación
  • Lin L; Department of Pathology, Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi China.
  • Wang Q; Department of Pathology, Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi China.
  • Xu F; Department of General Medicine, Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi China.
  • Luo X; Department of Breast Surgery, Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi China.
  • Xu J; Department of Pathology, Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi China.
  • Yan L; Department of Pathology, Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi China.
  • Li Q; Department of Pathology, Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi China.
  • Hao H; Department of Pathology, Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi China. Electronic address: haohua410@126.com.
Immunol Lett ; 253: 54-55, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36572610
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Immunol Lett Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Immunol Lett Año: 2023 Tipo del documento: Article